InSitu Biologics, Inc., 2026-08-10
A new SEC Form D private-offering notice from Oakdale, MN, a $2,500,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Near clinical stage biopharmaceutical company developing an injectable, sustained release ropivacaine based peripheral nerve block for post surgical pain management to reduce opioid reliance
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Vertical Insure, Inc., 2026-08-17, $21M, Minneapolis, MN
- Bullseye Biodevices, Inc., 2026-08-10, $1.3M, Hoboken, NJ
- Darcy Solutions, Inc., 2026-08-11, $20.4M, Saint Paul, MN
- Voyageur Pharmaceuticals Ltd., 2026-08-10, $4.8M, Calgary, AB, Canada
- Karousels Inc., 2026-08-10, $700K, Eagan, MN
- PLEOPHARMA, INC., 2026-08-10, $15M, Phoenixville, PA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.